Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
administered, analytical, behalf, biotechnology, director, dollar, effort, enabling, expended, feasibility, February, fee, formulation, IND, Investigational, mastectomy, preclinical, prophylactic, residual, route, stability, stake, subsequently, woman
Removed:
achieving, Additionally, alternative, amendment, American, animal, anticipate, April, assigned, ASU, authorized, awarded, began, beneficial, bioavailability, calculating, call, calling, Chairman, commence, conference, consisting, consultant, conversion, decide, decided, delivered, derivative, discover, discovery, divert, encrypted, entity, exceeding, fifteen, Freestanding, genetic, GmbH, identified, inhibiting, injectable, issuance, issuer, joint, June, main, meeting, modification, MolGenie, mother, OntoChem, oral, orally, pause, paused, Pfizer, promising, prosecute, protease, quarter, recruitment, removing, restart, scope, separation, specifically, structured, Subtopic, termination, treat, ultimately, unclear, viable, vitro, warrant, written
Filing tables
Filing exhibits
ANIX similar filings
Filing view
External links
Exhibit 32.1
Statement of Chief Executive Officer
Pursuant to Section 1350 of Title 18 of the United States Code
Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Dr. Amit Kumar, the Chairman and Chief Executive Officer of Anixa Biosciences, Inc., hereby certifies that:
1. | The Company’s Form 10-Q Quarterly Report for the period ended January 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Dr. Amit Kumar | |
Dr. Amit Kumar | |
Chairman and Chief Executive Officer | |
March 12, 2024 | (Principal Executive Officer) |